Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Synthesis of silver nanoparticles for the dual delivery of doxorubicin and alendronate to cancer cells
Thymosin Beta-4 Heritage: Parent compound is endogenous and well-characterized Clinical Trials: RegeneRx trials showed generally favorable safety in ophthalmic and cardiac applications Cancer Concerns: Theoretical concerns about cell migration and tumor potential
This structural modification allows IGF-1 LR3 to circulate unbound and biologically active for 2030 hours, whereas native IGF-1 remains more than 99% bound to IGFBP-3 with a half-life of only 10 minutes
Scientists have attached an acetyl group (COCH3) directly to the sulfur atom of the cysteine molecule within the glutathione structure
